Stada Grows In Russia And CIS With Takeda Brands
Executive Summary
Stada will pay $660m for a basket of 20 brands from Takeda to expand its consumer health portfolio in Russia and a number of strategically important CIS markets.
You may also be interested in...
Stada UK Head On COVID-19 Impact, Local Growth Strategy And OTC Brand Innovation
Exclusive: HBW Insight talks to Stada executive vice-president Roger Scarlett-Smith on the progress of the company's ambitious growth strategy, the impact of the coronavirus and its new innovation centre in Yorkshire, England.
Stada Takes Lead In Russia's OTC Market As Group Sales Rise Double-Digits
Stada has taken the lead in the Russian OTC market and is implementing a turnaround plan in the country to take the business to the next level.
Hypera Strikes Takeda Deal To Dominate Brazil's OTC Market
Brazil's Hypera is paying Takeda $0.8bn for a portfolio of brands which will make it the "undisputed leader" in the South American country's OTC market.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available Buy Reports
Need a specific report? 1000+ reports available Buy Reports
New to HBW Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: